Navigation Links
StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.

ProductsStemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
Company StemCell Technologies, Inc.
Item StemSep Rhesus CD4+ T Cells, 2 mL Kit
Price 
Description This depletion cocktail is tailored to highly enrich CD4+ T cells from suspensions of non-human primate (Rhesus monkey) cells. Cells are separated using the StemSep compatible 0.5 Tesla) immunomagnetic negative selection system. The CD4+ T cell content of the enriched fraction typically ranges from 93 to 99%.
Info StemCell Technologies, Inc.StemCell Technologies, Inc.
570 West Seventh Avenue, Suite 400
Vancouver, BC, V5Z 1B3
Canada
Customer Service:
(604) 877-0713
(800) 667-0322

Fax Number:
(604) 877-0704
(800) 567-2899

Web Site: http://www.stemcell.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. StemSep Hu-Mu Chimera Starter Kit, Kit from StemCell Technologies, Inc.
2. StemSep CD45RA Tetramer, 100 uL from StemCell Technologies, Inc.
3. StemSep Anti-Human CD69 Tetramer, 200 uL from StemCell Technologies, Inc.
4. StemSep anti-Hu TCR alpha beta, 200 uL from StemCell Technologies, Inc.
5. StemSep Anti-Hu HLA-DR Tetramer, 100 uL from StemCell Technologies, Inc.
6. StemSep Anti-Hu HLA-DR Tetramer, 200 uL from StemCell Technologies, Inc.
7. StemSep Rat CD4+ T Cells, 10 mL from StemCell Technologies, Inc.
8. StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
9. StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
10. StemSep Anti-Phycoertherin TAC, 2 mL from StemCell Technologies, Inc.
11. Rhesus Monkey IFN Alpha from PBL InterferonSource
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor...
Recombinant Rat CINC-2 beta, CF...
SHEEP ANTI FLECAINIDE...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Biology Products:
(Date:7/8/2015)... FRANKLIN LAKES , N.J. and NEW YORK ... and Company) and Guidepoint today announced ... selected start-up healthcare companies with free access to Guidepoint,s ... mentoring several start-ups that are developing cutting-edge technologies to ... of a dedicated Guidepoint research manager, each start-up entrepreneur ...
(Date:7/7/2015)... July 7, 2015  Based on its recent ... Sullivan recognizes Credence ID, LLC with the 2015 ... of the Year Award. Credence ID has developed ... its mission of offering enrollment and identification solutions ... Credence ID was formed by experts from the ...
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... view, rice fields in California,s Yolo Bypass provide,an ... their journey to the sea. That,s according to ... experiment that planted fish,in harvested rice fields earlier ... record in the state,s rivers. The report, ...
... hair cells, sensory receptors that mechanically amplify low-level sound that ... transduction channel was characterized more than 30 years ago, researchers ... study in The Journal of General Physiology ... mystery channel. Recent studies have suggested that members ...
... of 26 nursing homes in Orange County, California carry ... more easily, and may cause more severe infection than ... paper published in the November 2013 issue of the ... homes need to be part of MRSA control strategies ...
Cached Biology News:For fish and rice to thrive in Yolo Bypass, 'just add water' 2For fish and rice to thrive in Yolo Bypass, 'just add water' 3Copious community-associated MRSA in nursing homes 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... Ascendis Pharma A/S (Nasdaq: ASND ... TransCon technology to address significant unmet medical needs, ... Phase 2 study to evaluate the safety and ... treatment-naïve, pre-pubertal children with growth hormone deficiency, or ... the top-line results from our Phase 2 pediatric ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's ... designed for continuous operation up to 1500 bar. The sanitary design gauge of ... preventing toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for ...
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10